PDT in squamous cell carcinoma of the skin

Giornale Italiano di Dermatologia e Venereologia

Volumn 146, Issue 6, 2011, Pages 431-444

  Zwiebel, S ^a   Baron, E ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

Carcinoma, squamous cell; Photosensitizing agents; Precancerous conditions; Skin diseases; Skin neoplasms

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; CANCER VACCINE; CASPASE 3; CYTOCHROME C; FLUOROURACIL; PHOTOFRIN; REACTIVE OXYGEN METABOLITE;

ACTINIC KERATOSIS; APOPTOSIS; BLUE LIGHT; BOWEN DISEASE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CELL VACUOLE; CRYOTHERAPY; DOWN REGULATION; DRUG CLEARANCE; DRUG INDICATION; DRUG PENETRATION; ENDOPLASMIC RETICULUM; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HERPES SIMPLEX; HUMAN; HYPERTHERMIA; LIGHT EMITTING DIODE; LIPOPHILICITY; LUNG CANCER; MITOCHONDRIAL MEMBRANE POTENTIAL; MULTICENTER STUDY (TOPIC); NERVE ENDING; ORGAN TRANSPLANTATION; OROPHARYNX CANCER; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PAIN; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PULSED DYE LASER; RED LIGHT; REVIEW; SKIN CARCINOMA; SKIN PENETRATION; SQUAMOUS CELL CARCINOMA; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; VIRUS REACTIVATION;

EID: 84856939856     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Babilas P, Schreml S, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology: state-of-the-art. Photodermatol Photoimmunol Photomed 2010;26:118-32.
2. Tierney E, Barker A, Ahdout J, Hanke CW, Moy RL, Kouba DJ. Photodynamic therapy for the treatment of cutaneous neoplasia, inflammatory disorders, and photoaging. Dermatol Surg 2009;35:725-46.
3. Szeimies RM, Dräger J, Abels C, Landthaler M. History of photodynamic therapy in dermatology. Photodynamic therapy and fluorescence diagnosis in dermatology. Amsterdam: Elsevier 2001;3-15.
4. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990;6:143-8.
5. Kloek J, Akkermans W, Beijersbergen van Henegouwen GM. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem Photobiol 1998;67:150-4. (Pubitemid 128471973)
6. Arits AH, van de Weert MM, Nelemans PJ, Kelleners-Smeets NW. Pain during topical photodynamic therapy: uncomfortable and unpredictable. J Eur Acad Dermatol Venereol 2010;24:1452-7.
7. Moloney FJ, Collins P. Randomized, double-blind, prospective study to compare topical 5-aminolevulinic acid methylester with topical 5-aminolevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol 2007;157:87-91. (Pubitemid 46934264)
8. Moriwaki SI, Misawa J, Yoshinari Y, Yamada I, Takigawa M, Tokura Y. Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin). Photodermatol Photoimmunol Photomed 2001;17:241-3. (Pubitemid 32834293)
9. Karakullukcu B, van Oudenaarde K, Cooper MP, Klop WM, van Veen R, Wildeman M et al. Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients. Eur Arch Otorhinolaryngol 2011;268:281-8.
10. Morton CA, Horn M, Leman J, Tack B, Bedane C, Tijoe M et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cells carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol 2006;142:729-35.
11. Lee J, Moon C. Current status of experimental therapeutics for head and neck cancer. Exp Biol Med (Maywood) 2011;236:375-89.
12. Calzavara-Pinton PG, Venturini M, Sala R, Capezzera R, Parrinello G, Specchia C et al. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Br J Dermatol 2008;159:137-44. (Pubitemid 351874478)
13. Allison RR, Sibata CH. Oncologic photodynamic therapy photosensitizers: a clinical review. Photodiagnosis Photodyn Med 2010;7:61-75.
14. Hsieh YJ, Yu JS, Lyu PC. Characterization of photodynamic therapy responses elicited in A431 cells containing intracellular organelle-localized photofrin. J Cell Biochem 2010;111:821-33.
15. Bredell MG, Besic E, Maake C, Walt H. The application and challenges of clinical PD-PDT in the head and neck region: a short review. J Photochem Photobiol B 2010;101:185-90.
16. Schweitzer VG, Somers ML. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage (Tis-T2N0M0) SqCCa of oral cavity and oropharynx. Lasers Surg Med 2010;42:1-8.
17. Dougherty TJ, Cooper MT, Mang TS. Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg Med 1990;10:485-8. (Pubitemid 20366419)
18. Miller JD, Baron ED, Scull H, Hsia A, Berlin JC, McCormick T et al. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies. Toxicol Appl Pharmacol 2007;224:290-9. (Pubitemid 47575679)
19. Kalisiak MS, Rao J. Photodynamic therapy for actinic keratoses. Dermatol Clin 2007;25:15-23. (Pubitemid 44780060)
20. Chen X, Zhao P, Chen F, Li L, Luo R. Effect and mechanism of 5-aminolevulinic acid-mediated photodynamic therapy in esophageal cancer. Lasers Med Sci 2011;26:69-78.
21. Anand S, Honari G, Hasan T, Elson P, Maytin EV. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clin Cancer Res 2009;15:3333-43.
22. Cicarma E, Tuorkey M, Juzeniene A, Ma LW, Moan J. Calcitriol treatment improves methyl aminolevulinate-based photodynamic therapy in human squamous cell carcinoma A431 cells. Br J Dermatol 2009;16:413-8.
23. Smits T, van Laarhoven AI, Staassen A, van de Kerkhof PC, van Erp PE, Gerritsen MJ. Induction of protoporphyrin IX by aminolevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells. Br J Dermatol 2009;160:849-57.
24. Juzenas P, Juzeniene A, Kaalhus O, Iani V, Moan J. Noninvasive fluorescence excitation spectroscopy during application of 5-aminolevulinic acid in vivo. Photochem Photobiol Sci 2002;1:745-8. (Pubitemid 37069793)
25. Morton CA, McKenna KE, Rhodes LE; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. Guidelines for topical for photodynamic therapy: update. Br J Dermatol 2008;159:1245-66.
26. Calin MA, Diaconeasa A, Savastru D, Tautan M. Photosensitizers and light sources for photodynamic therapy of the Bowen's disease. Arch Dermatol Res 2011;303:145-51.
27. Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci 2002;17:173-86.
28. Strasswimmer J, Grande DJ. Do pulsed lasers produce an effective photodynamic therapy response? Lasers Surg Med 2006;38:22-5. (Pubitemid 43238081)
29. Britton JE, Goulden V, Stables G, Stringer M, Sheehan-Dare R. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolevulinic acid phototherapy. Br J Dermatol 2005;153:780-4. (Pubitemid 41415905)
30. Maisch T, Moor AC, Regensburger J, Ortland C, Szeimies RM, Bäumler W. Intense pulse light and 5-ALA PDT: phototoxic effects in vitro depend on the spectral overlap with Protoporphyrine IX but do not match cut-off filter notations. Lasers Surg Med 2011;43:176-82.
31. Babilas P, Knobler R, Hummel S, Gattschaller C, Maisch T, Koller M et al. Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. Br J Dermatol 2007;157:111-7. (Pubitemid 46934274)
32. Szeimies RM, Matheson RT, Davis SA, Bhatia AC, Frambach Y, Klövekorn W et al. Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study. Dermatol Surg 2009;35:586-92.
33. Ritter CG, Kuhl IC, Lenhardt C, Weissbluth, ML, Bakos RM. Photodynamic therapy with delta-aminolevulinic acid and light-emitting diodes in actinic keratosis. An Bras Dermatol 2010;85:639-45.
34. Nobbe S, Trüeb RM, French LE, Hofbauer GF. Herpes simplex virus reactivation as a complication of photodynamic therapy. Photodermatol Photoimmunol Photomed 2011;27:51-2.
35. Wiegell SR, Haederdsdal M, Wulf HC. Cold water and pauses in illumination reduces pain during photodynamic therapy: a randomized clinical study. Acta Derm Venereol 2009;89:145-9.
36. Sotirou E, Apalla Z, Ionnides D. Complete resolution of a squamous cell carcinoma of skin using intralesional 5-aminolevulinic acid photodynamic therapy intralesional PDT for SCC. Photodermatol Photoimmunol Photomed 2010;26:269-71.
37. Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB; Phase IV ALA-PDT Actinic Keratosis Study Group. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol 2006;155:1262-9. (Pubitemid 44730005)
38. Willey A, Mehta S, Lee PK. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. Dermatol Surg 2010;36:652-8.
39. Piacquiado DJ, Chen DM, Farber HF, Fowler JF Jr, Glazer SD, Goodman JJ et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratosis of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol 2004;140:41-6. (Pubitemid 38090269)
40. Morton C, Horn M, Leman J, Tack B, Bedane C, Tjioe M et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy of Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Arch Dermatol 2006;142:729-35.
41. Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Dermato Venereol 2006;86:25-8. (Pubitemid 46939784)
42. Kessel D, Luo Y. Photodynamic therapy: a mitochondrial inducer of apoptosis. Cell Death Differ 1999;6:28-35. (Pubitemid 29051852)
43. Kessel D, Castelli M. Evidence that bcl-2 is the target of three photosensitizers that induce a rapid apoptotic response. Photochem and Photobiol 2001;74:318-22.
44. Tsaytler PA, O'Flaherty MC, Sakharov DV, Krigsveld J, Egmond MR. Immediate protein targets of photodynamic treatment in carcinoma cells. J Photochem Res 2008;7:3868-78.
45. Reiners JJ Jr, Caruso JA, Mathieu P, Chelladurai B, Yin XM, Kessel D. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ 2002;9:934-44. (Pubitemid 35033432)
46. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, Schlesinger PH. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 2000;7:1166-73. (Pubitemid 32042223)
47. Sanovic R, Krammer B, Grumboeck S, Verwanger T. Time-resolved gene expression profiling of human squamous cell carcinoma cells during the apoptosis process induced by photodynamic treatment with hypericin. Int J Oncol 2009;35:921-39.
48. Korbelik M, Cecic I. Complement activation cascade and its regulation: relevance for the response of solid tumors to photodynamic therapy. J Photochem Photobiol B 2008;93:53-9.
49. Gorter A, Meri S. Immune evasion of tumor cells using membrane-bound complement regulatory proteins. Immunol Today 1999;20:576-82.
50. Horn M, Wolf P, Wulf HC, Warloe T, Fritsch C, Rhodes LE et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003;149:1242-9. (Pubitemid 38058101)
51. Li Q, Gao T, Long HA, Ujiie H. Clearance of a thick invasive squamous cell carcinoma after multiple treatments with topical photodynamic therapy. Photomed Laser Surg 2010;28:705-6.
52. Hu A, Moore C, Yu E, Mount G, Jordan K, Vuiovic O et al. Evaluation of patient-perceived satisfaction with photodynamic therapy for Bowen Disease. J Otolaryngol Head Neck Surg 2010;39:688-96.
53. Szeimies RM, Karrer S, Radakovic-Filan S, Tane A, Calzavara-Pinton PG, Zane C et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective randomized study. J Am Acad Dermatol 2002;47:258-62.
54. Morton C, Campbell S, Gupta G, Keohane S, Lear J, Zaki I et al.; AKtion Investigators. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006;155:1029-36. (Pubitemid 44564515)
55. Morton CA. Methyl aminolevulate: actinic keratoses and Bowen's disease. Dermatol Clin 2007;25:81-7. (Pubitemid 44780063)
56. Wennberg AM, Stenquist B, Stockfleth E, Keohane S, Lear JT, Jemec G et al. Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study. Transplantation 2008;86:423-9.
57. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D et al.; International Society for Photodynamic Therapy in Dermatology. Guidelines on the use of photodynamic therapy for nonemelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007;56:125-43. (Pubitemid 44969292)
58. Tierney EP, Eide MJ, Jacobsen G, Ozog D. Photodynamic therapy for actinic keratoses: survery of patient perceptionis of treatment satisfaction and outcomes. J Cosmet Laser Ther 2008;10:81-6. (Pubitemid 351883332)
59. Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Dermato Venereol 2005;85:424-8. (Pubitemid 41345617)
60. Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P. A comparison of photodynamic therapy topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003;14:99-106. (Pubitemid 36648700)
61. Kaufmann R, Spelman L, Weightman W, Reifenberger J, Szeimies RM, Verhaeghe E et al. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Br J Dermatol 2008;158:994-9. (Pubitemid 351521450)
62. Moreno G, Chia AL, Lim A, Shumack S. Therapeutic options for Bowen's disease. Australas J Dermatol 2007;48:1-8.
63. Salim A, Leman JA, McColl JH, Chapman R, Morton CA. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2003;148:539-43. (Pubitemid 36461334)
64. Morton CA, Whitehurst C, McColl JH, Moore JV, MacKie RM. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol;137:319-24.
65. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol 1993;28:17-21. (Pubitemid 23019558)
66. Tanaka T, Matono S, Nagano T, Murata K, Sueyoshi S, Yamana H et al. Photodynamic therapy for large superficial squamous cell carcinoma of the esophagus. Gastrointest Endosc 2011;73:1-6.
67. Uekusa M, Omura K, Nakajima Y, Hasegawa S, Harada H, Morita KI et al. Uptake and kinetics of 5-aminolevulinic acid in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2010;39:802-5.
68. De Graaf YG, Kennedy C, Wolterbeek R, Collen AF, Willemze R, Bouwes Bavinck JN. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol 2006;126:569-74. (Pubitemid 43255643)
69. Sandberg C, Stenquist B, Rosdahl I, Ros AM, Synnerstad I, Karlsson M et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Dermato Venereol 2006;86:404-8. (Pubitemid 44450094)
70. Halldin CB, Paoli J, Sandberg C, Gonzalez H, Wennberg AM. Nerve blocks enable adequate pain relief during topical photodynamic therapy of field cancerization on the forehead and scalp. Br J Dermatol 2009;160:795-800.
71. Wiegell SR, Skiveren J, Philipsen PA, Wulf HC. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 2010;158:727-33. (Pubitemid 351415749)
72. Hauschild A, Stockfleth E, Popp G, Borrosch F, Brüning H, Dominicus R et al. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolevulinic acid path: results of two randomized controlled phase III studies. Br J Dermatol 2009;160:1066-74.
73. Hauschild A, Popp G, Stockfleth E, Meyer KG, Imberger D, Mohr P et al. Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolevulinic acid patch. Exp Dermatol 2009;18:116-21.
74. Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V et al. Novel patch-based systems for the localised delivery of ALA-esters. J Photochem Photobiol B 2010;101:59-69.
75. Smetana Z, Ben-Hur E, Mendelson E, Salzber S, Wagner P, Malik Z. Herpes simplex virus proteins are damaged following photodynamic inactivation with phthalocyanines. J Photochem Photobiol B 1998;44:77-83. (Pubitemid 28423130)
76. Marotti J, Aranha AC, Eduardo Cde P, Ribeiro MS. Photodynamic therapy can be effective as a treatment for herpes simplex labialis. Photomed Laser Surg 2009;27:357-63.
77. Yoon KC, Im SK, Park HY. Recurrent herpes simplex keratitis after verteporfin photodynamic therapy for corneal neovascularization. Cornea 2010;29:465-7.
78. Korbelik M, Stott B, Sun J. Photodynamic therapy-generated vaccines: relevance of tumour cell death expression. Br J Cancer 2007;97:1381-7. (Pubitemid 350114797)
79. Korbelik M. Photodynamic therapy-generated cancer vaccines. Methods Mol Biol 2010;635:147-53.